Acetaldehyde

Acetaldehyde

SCHEMBL889473

[2H]C(C)=O

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Acetaldehyde SCHEMBL10051938 1.00
Acetaldehyde SCHEMBL557459 0.78
Acetaldehyde SCHEMBL1330497 0.72
SCHEMBL16550695 0.72
Acetaldehyde SCHEMBL6747 0.72
Acetaldehyde SCHEMBL1331732 0.72
Acetaldehyde SCHEMBL20411618 0.72
Acetaldehyde SCHEMBL3945841 0.72
Acetaldehyde SCHEMBL2338299 0.72
Acetaldehyde SCHEMBL25291303 0.67

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 87 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118076701-A Composition and method for producing the same 默克专利股份有限公司 2024-05-24 CN claimed
EP-4689155-A1 USE OF INHIBITORS TO INCREASE EFFICIENCY OF CRISPR/CAS INSERTIONS Astrazeneca AB (SE) 2026-02-11 EP disclosed
EP-4630410-A1 POLQ INHIBITORS Astrazeneca AB (SE) 2025-10-15 EP disclosed
CN-118891584-A Casting paint for screen printing 巴斯夫欧洲公司 2024-11-01 CN disclosed
WO-2024201368-A1 USE OF INHIBITORS TO INCREASE EFFICIENCY OF CRISPR/CAS INSERTIONS ASTRAZENECA AB (SE) 2024-10-03 WO disclosed
CN-113316744-B Oxime ester photoinitiators with special aroyl chromophores 巴斯夫欧洲公司 2024-07-30 CN disclosed
WO-2024121753-A1 POLQ INHIBITORS ASTRAZENECA AB (SE) 2024-06-13 WO disclosed
CN-118103478-A Composition and method for producing the same 默克专利股份有限公司 2024-05-28 CN disclosed
CN-110007563-B Negative photosensitive resin composition, spacer, protective film, and liquid crystal display element 奇美实业股份有限公司 2024-04-02 CN disclosed
CN-113906020-B Cyclic bradykinin B2 receptor antagonists 法瓦里斯有限责任公司 2024-03-12 CN disclosed
US-7579334-B2 Compounds with anti-inflammatory activity GLAXOSMITHKLINE ISTRAZIVACKI CENTAR ZAGREB (HR) 2009-08-25 US disclosed
US-20090176776-A1 SMALL MOLECULE INHIBITORS OF HIV-1 CAPSID ASSEMBLY UNIVERSITY OF ALABAMA AT BIRMINGHAM (US) 2009-07-09 US disclosed
US-7371779-B2 Synergistic compositions of N-acylhomoserine lactones and 4-quinolones THE SECRETARY OF STATE FOR DEFENSE SCIENCE AND TECHNOLOGY (GB) 2008-05-13 US disclosed
US-20080096830-A1 Anti-Inflammatory Macrolide Conjugates GLAXOSMITHKLINE ISTRAZIVACKI CENTAR ZAGREB D.O.O. (HR) 2008-04-24 US disclosed
US-20080090803-A1 FATTY ALCOHOL DRUG CONJUGATES LUITPOLD PHARMACEUTICALS, INC. (US) 2008-04-17 US disclosed
US-20080081807-A1 Arylphenyl-substituted cyclic keto-enols LIEB FOLKER 2008-04-03 US disclosed
US-20080050833-A1 Ionizable isotopic labeling reagents for relative quantification by mass spectrometry THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS 2008-02-28 US disclosed
US-7323536-B2 Reaction product obtained by melt blending an aromatic polyester-polycarbonate and a transesterification catalyst that has a haze of less than 5.0% GENERAL ELECTRIC COMPANY (US) 2008-01-29 US disclosed
US-7320984-B2 Remedies or preventives for urinary frequency or urinary incontinence and morphinan derivatives having nitrogen-containing heterocyclic group TORAY INDUSTRIES, INC. (JP) 2008-01-22 US disclosed
US-20070015757-A1 Novel Glucagon Antagonists/Inverse Agonists NOVO NORDISK A/S (DK) 2007-01-18 US disclosed